Minor groove dimeric bisbenzimidazoles inhibit in vitro DNA binding to eukaryotic DNA topoisomerase I
Olga Yu. Susova, Anatoly A. Ivanov, Sandra Morales Ruiz, Ekaterina A. Lesovaya, A. V. Gromyko, Sergey A. Streltsov, Alexei L. Zhuze
Abstract
Olga Yu. Susova, Anatoly A. Ivanov, Sandra Morales Ruiz, Ekaterina A. Lesovaya, A. V. Gromyko, Sergey A. Streltsov, Alexei L. Zhuze
Abstract
The potential of six dimeric bisbenzimidazoles bound to scDNA to inhibit eukaryotic DNA topoisomerase (topo-I) was studied chemically; the tested compounds differed in linker structure and length. All the compounds inhibited topo-I, DB(7) being the most efficient; its inhibitory activity in vitro was 50-fold higher than that of camptothecin. It is noteworthy that inhibitory properties of nearly all the tested compounds increased many times if they were preincubated with scDNA for three days.
OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The potential of six dimeric bisbenzimidazoles bound to scDNA to inhibit eukaryotic DNA topoisomerase (topo-I) was studied chemically; the tested compounds differed in linker structure and length. All the compounds inhibited topo-I, DB(7) being the most efficient; its inhibitory activity in vitro was 50-fold higher than that of camptothecin. It is noteworthy that inhibitory properties of nearly all the tested compounds increased many times if they were preincubated with scDNA for three days.
Key concepts: Topoisomerase, Minor groove, Camptothecin, DNA, In vitro, Linker, Chemistry, Molecular biology